生物标志物对免疫检查点抑制剂相关心肌炎患者激素抵抗及预后的预测价值OA
Predictive value of biomarkers for steroid resistance and prognosis in patients with immune checkpoint inhibitor-associated myocarditis
目的 探讨血清标志物可溶性生长刺激表达基因 2蛋白(soluble growth stimulation expressed gene 2 protein,sST2)、心肌肌钙蛋白 T(cardiac troponin T,cTnT)、肌酸激酶同工酶(creatine kinase-myocardial band,CK-MB)预测免疫检查点抑制剂相关心肌炎(immune checkpoint inhibitor-associated myocarditis,ICIAM)患者激素抵抗及预后的预测价值.方法 前瞻性纳入 2023年 3月至 2024年 2 月在复旦大学附属中山医院诊治的 28例 ICIAM患者,分为激素抵抗型ICIAM(steroid-resistant ICIAM,srICIAM)组与非 srICIAM组.检测患者治疗前 sST2、cTnT、CK-MB水平,通过ROC曲线分析预测 srICIAM的效能.通过 Kaplan-Meier法评估 sST2与全因死亡率的关系.结果 srICIAM组(n=15)基线 sST2、cTnT、CK-MB 水平较非 srICIAM组(n=13)升高(P<0.05).cTnT联合 sST2预测 srICIAM的效能最优(AUC=0.857,灵敏度 0.714、特异度 1.000).随访 6个月时,高 sST2组全因死亡率高于低 sST2组(P=0.016).结论 sST2联合 cTnT可有效预测 srICIAM;高 sST2与 ICIAM患者的全因死亡率升高相关,能为早期风险分层与治疗优化提供依据.
Objective To investigate predictive value of soluble growth stimulation-expressed gene 2 protein(sST2),cardiac troponin T(cTnT),and creatine kinase-myocardial band(CK-MB)for steroid resistance and prognosis in patients with immune checkpoint inhibitor-associated myocarditis(ICIAM).Methods A total of 28 patients with ICIAM were prospectively enrolled from March 2023 to February 2024 at Zhongshan Hospital,Fudan University.All participants were divided into the steroid-resistant ICIAM(srICIAM)group and the non-srICIAM group.Baseline serum levels of sST2,cTnT and CK-MB were detected prior to treatment initiation.ROC curve analysis was applied to evaluate the predictive value of these biomarkers,and Kaplan-Meier survival analysis was performed to explore the relationship between sST2 and all-cause mortality.Results Baseline sST2,cTnT,and CK-MB levels were significantly higher in the srICIAM group(n=15)than in the non-srICIAM group(n=13,P<0.05).Combination of cTnT and sST2 improved predictive performance for srICIAM(AUC=0.857,sensitivity 0.714,specificity 1.000).After 6 months of follow-up,the high sST2 group had a significantly higher all-cause mortality than the low sST2 group(P=0.016).Conclusions The combination of sST2 and cTnT could effectively predict srICIAM,and elevated sST2 is associated with increased higher all-cause mortality in ICIAM patients,providing a basis for early risk stratification and treatment optimization.
王尹曼;蔡青青;王妍;刘媛;吕迁洲;程蕾蕾
复旦大学附属中山医院心内科,上海 200032||上海市心血管病研究所,上海 200032||心脏病全国重点实验室,上海 200032||国家放射与治疗临床医学研究中心,上海 200032||复旦大学肿瘤心脏病研究所(筹),上海 200032复旦大学肿瘤心脏病研究所(筹),上海 200032||复旦大学附属中山医院药剂科,上海 200032复旦大学肿瘤心脏病研究所(筹),上海 200032||复旦大学附属中山医院肿瘤内科,上海 200032复旦大学附属中山医院心内科,上海 200032||上海市心血管病研究所,上海 200032||心脏病全国重点实验室,上海 200032||国家放射与治疗临床医学研究中心,上海 200032||复旦大学肿瘤心脏病研究所(筹),上海 200032复旦大学附属中山医院药剂科,上海 200032上海市心血管病研究所,上海 200032||心脏病全国重点实验室,上海 200032||复旦大学肿瘤心脏病研究所(筹),上海 200032||复旦大学附属中山医院心脏超声诊断科,上海 200032||上海市影像医学研究所,上海 200032
医药卫生
免疫检查点抑制剂相关心肌炎生长刺激表达基因2蛋白心肌肌钙蛋白T激素抵抗预后
immune checkpoint inhibitor-associated myocarditisgrowth stimulation expressed gene 2 proteincardiac troponin Tsteroid resistanceprognosis
《中国临床医学》 2026 (4)
607-614,8
四大慢病重大专项(2023ZD0502800),国家自然科学基金(82170359、82470354).Supported by Noncommunicable Chronic Diseases-National Science and Technology Major Project(2023ZD0502800)and National Natural Science Foundation of China(82170359,82470354).
评论